Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133531) titled 'Clinical study of 99mTc-PSMA SPECT/CT in the diagnosis of suspected recurrence after radical prostatectomy' on Sept. 29.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai General Hospital
Condition:
prostate cancer
Intervention:
Gold Standard:Pathological results or composite diagnostic criteria were used as the gold standard.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Target condition:50;Difficult condition:50
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/show...